As a strategic business partner,
MedAssets can replace multiple
vendors and
decrease supply costs by
3-10 %,
increase net patient revenue by
1-3 %, and deliver
additional cash from existing
operations — the equivalent of up to
2 points in operating profit
margin.*
|
 |
|
1 |
|
|
|
2 |
|
|
|
2 |
|
|
|
2 |
|
|
|
2 |
|
|
|
|
|
|
*Results may vary.
Securities offered through Purshe Kaplan Sterling Investments,
Member FINRA/SIPC, Headquartered at 18 Corporate Woods Blvd., Albany
New York 12211.
www.finra.org
|
